Logo Logo
Hilfe
Hilfe
Switch Language to English

Hannah-Shmouni, Fady; Berthon, Annabel; Faucz, Fabio R.; Briceno, Juan Medina; Maria, Andrea Gutierrez; Demidowich, Andrew; Peitzsch, Mirko; Masjkur, Jimmy; Bonnet-Serrano, Fideline; Vaczlavik, Anna; Bertherat, Jerome; Reincke, Martin; Eisenhofer, Graeme und Stratakis, Constantine A. (2020): Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia. In: Endocrine-Related Cancer, Bd. 27, Nr. 7: S. 403-413

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Biochemical characterization of primary bilateral macronodular adrenocortical hyperplasia (PBMAH) by distinct plasma steroid profiles and its putative correlation to disease has not been previously studied. LC- MS/MS-based steroid profiling of 16 plasma steroids was applied to 36 subjects (22 females, 14 males) with PBMAH, 19 subjects (16 females, 3 males) with other forms of adrenal Cushing's syn drome (ACS), and an age and sex-matched control group. Germline ARMC5 sequencing was performed in all PBMAH cases. Compared to controls, PBMAH showed increased plasma 11-deoxycortisol, corticosterone, 11-deoxycorticosterone, 18-hydroxycortisol, and aldosterone, but lower progesterone, DHEA, and DHEA-S with distinct differences in subjects with and without pathogenic variants in ARMC5. Steroids that showed isolated differences included cortisol and 18-oxocortisol with higher (P < 0.05) concentrations in ACS than in controls and aldosterone with higher concentrations in PBMAH when compared to controls. Larger differences in PBMAH than with ACS were most clear for co rticosterone, but there were also trends in this direction for 18-hydroxycortisol and aldosterone. Logistic regression analysis indicated four steroids - DHEA, 11-deoxycortisol, 18-oxocortisol, and corticosterone - with the most power for distinguishing the groups. Discriminant analyses with step- wise variable selection indicated correct classification of 95.2% of all subjects of the four groups using a panel of nine steroids;correct classification of subjects with and without germline variants in ARMC5 was achieved in 91.7% of subjects with PBMAH. Subjects with PBMAH show distinctive plasma steroid profiles that may offer a supplementary single-test alternative for screening purposes.

Dokument bearbeiten Dokument bearbeiten